Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
Today is the last day to save $2,605. Character of the market is changing. What worked in the last nine years is not likely to work in the future and may produce losses. The time to fine tune your skills for the future is now. Act now to register. Technology
This post was just published on ZYX Buy Change Alert. In our divided country there are very few things on which Republicans and Democrats, liberals and conservatives agree. One of those very few things is that drug prices are too high. It makes no sense for Americans to often pay ten times
Republicans have finally produced a detailed plan to repeal and replace the Affordable Care Act, also known as Obamacare. Setting aside politics and viewing the plan neutrally, two things jump out. First, the House Republicans’ plan keeps the basic framework of Obamacare. No wonder some are calling it “Obamacare Lite.”
President Trump’s tweet accusing his predecessor of wiretapping him during the campaign — followed by Barack Obama’s denial — has created a highly sensitive subject for many people. With this type of allegation flying around, investors must be pragmatic and review the hard data without a political lens. This is
Donald Trump is starting his first full week as U.S. president. Bearish investors have been out in full force, proclaiming, with high confidence, that it’s time to sell stocks. At the same time, bullish gurus are saying just the opposite. So who’s right? Let’s explore the answer. First, we need
Donald Trump knocked yet another industry in his press conference Wednesday, but this time it wasn’t manufacturers or car makers. It was health care. And shares of U.S. pharmaceutical companies promptly fell, dropping by an average range of about 3% to 5%. “We’ve got to get our drug industry back,”
This post was published on ZYX Buy Change Alert. Initiate or add in the zone of $13.50 to $14.52. Suitable only for aggressive investors More later as it is moving fast. COMMENT $LABD $IBB $XBI $PJP $PPH $XPH $IHE $BMY $MRK As a full disclosure, paying subscribers to ZYX Buy Change Alert
I can safely say that, from my 35 years in the financial markets, to be consistently successful at investing, one must put prudence over popularity. Human nature as it is, investors often find it difficult to take unpopular actions. My motivation in writing this column is to nudge you